Skip to main content

Table 1 Details of patients participating in this study

From: Can urinary exosomes act as treatment response markers in prostate cancer?

Patient

Clinical Stage

(all N0)

Gleason Score

Age

(years)

Serum PSA

ADT4

(ng/ml)

Serum PSA

ADT12

(ng/ml)

Serum PSA

at 6 months

(ng/ml)

1

T2b

7 (3+4)

66

10.5

2.10

1.2

2

T2b

7 (3+4)

62

134.0

0.20

<0.01

3

T2

8 (3+5)

70

8.3

1.40

<0.1

4†

n/d

7 (3+4)

65

83.2

83.40

†

5

T2c

7 (3+4)

69

95.2

4.10

<0.1

6

T2

8 (4+4)

70

10.8

0.10

<0.1

7

T3a

7 (3+4)

53

36.5

7.20

0.3

8

T3b

6 (3+3)

61

14.1

0.80

0

9

T2

7 (4+3)

66

21.1

0.20

<0.1

10

T2

8 (4+4)

71

28.1

1.3

n/d

  1. † Patient died from an unrelated brain tumour prior to Radiation Treatment.
  2. n/d not determined.